These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4746969)

  • 1. Efficacy of continuous intra-oesophageal antacid drip therapy in the treatment of reflux oesophagitis. A quantitative assessment using the acid perfusion test.
    Serebro HA; Friedman M; Beck IT
    S Afr Med J; 1973 Sep; 47(36):1656-9. PubMed ID: 4746969
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mucaine on reflux oesophagitis. A study using oesophageal perfusion test.
    Barker JR; Spencer J
    Br J Clin Pract; 1970 Oct; 24(10):417-8. PubMed ID: 5528150
    [No Abstract]   [Full Text] [Related]  

  • 4. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Romaniello G; Capobianco S; Auricchio S
    Arch Dis Child; 1984 Sep; 59(9):842-7. PubMed ID: 6385868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of a new formulation of almagate on gastroesophageal reflux in esophagitis patients. A randomized, single-blind and cross-over study].
    Grande Posa L; Lacima Vidal G; Pérez-Campos A
    Rev Esp Enferm Dig; 1993 Apr; 83(4):229-34. PubMed ID: 8494650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quigel: a new antacid-anti-gastric refluc agent].
    Bianchi BG
    Minerva Dietol Gastroenterol; 1979; 25(1):81-4. PubMed ID: 450266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 8. Reflux esophagitis. A comparison of old and new medical management.
    Grossmann AE; Klotz AP; Rhodes JB; Korb T
    J Kans Med Soc; 1973 Nov; 74(11):423-4. PubMed ID: 4357380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux].
    Iacono G; Carroccio A; Montalto G; Cavataio F; Ippolito S; Kazmierska I; Balsamo V
    Minerva Pediatr; 1991 Dec; 43(12):797-800. PubMed ID: 1798406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural history of gastro-oesophageal reflux disease without oesophagitis.
    Pace F; Santalucia F; Bianchi Porro G
    Gut; 1991 Aug; 32(8):845-8. PubMed ID: 1885063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study.
    Desechalliers JP; Galmiche JP; Touchais JY; Denis P; Colin R
    Int J Clin Pharmacol Res; 1984; 4(3):217-22. PubMed ID: 6092288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CONSTANT INTRAESOPHAGEAL ANTACID DRIP AS A METHOD OF TREATMENT OF REFLUX ESOPHAGITIS.
    BECK IT; LACERTE M; SOLYMAR J; RONA S
    Can Med Assoc J; 1964 Feb; 90(9):570-4. PubMed ID: 14118700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of peroral antacid treatment in patients with acute upper gastrointestinal haemorrhage: a randomized controlled trial.
    Kittang E; Aadland E; Oyen D; Holm HA; Berstad A; Pytte R; Qvigstad T; Tommelstad T
    Scand J Gastroenterol Suppl; 1982; 75():109-12. PubMed ID: 6755651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastroesophageal reflux disease during pregnancy].
    Elokhina TB; Tiutiunnik VL
    Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
    [No Abstract]   [Full Text] [Related]  

  • 18. Healing of duodenal ulcer with an antacid regimen.
    Peterson WL; Sturdevant RA; Frankl HD; Richardson CT; Isenberg JI; Elashoff JD; Sones JQ; Gross RA; McCallum RW; Fordtran JS
    N Engl J Med; 1977 Aug; 297(7):341-5. PubMed ID: 876324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.
    Grove O; Bekker C; Jeppe-Hansen MG; Karstoft E; Sanchez G; Axelsson CK; Nielsen HO; Andersen B; Rask-Madsen J
    Scand J Gastroenterol; 1985 May; 20(4):457-61. PubMed ID: 3895381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
    Graham DY; Patterson DJ
    Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.